Selenoproteins are rare proteins among all kingdoms of life containing the 21 amino acid, selenocysteine. Selenocysteine resembles cysteine, differing only by the substitution of selenium for sulfur. Yet the actual advantage of selenolate- versus thiolate-based catalysis has remained enigmatic, as most of the known selenoproteins also exist as cysteine-containing homologs. Here, we demonstrate that selenolate-based catalysis of the essential mammalian selenoprotein GPX4 is unexpectedly dispensable for normal embryogenesis. Yet the survival of a specific type of interneurons emerges to exclusively depend on selenocysteine-containing GPX4, thereby preventing fatal epileptic seizures. Mechanistically, selenocysteine utilization by GPX4 confers exquisite resistance to irreversible overoxidation as cells expressing a cysteine variant are highly sensitive toward peroxide-induced ferroptosis. Remarkably, concomitant deletion of all selenoproteins in Gpx4 cells revealed that selenoproteins are dispensable for cell viability provided partial GPX4 activity is retained. Conclusively, 200 years after its discovery, a specific and indispensable role for selenium is provided.

PERK 1,2 . By contrast, the effects of CDDO on CHOP were not blunted by any individual EIF2α kinase deficiency (Extended Data Fig. 1g) , possibly owing to the limited specificity of related compounds 11 . The comparative interrogation of CHOP regulators following three distinct cellular insults allowed us to differentiate global regulators of CHOP biology (Extended Data Fig. 1h-m) from such selectively operating in the context of CCCP-induced mitochondrial depolarization (Extended Data Figs. 2-4). In particular, stringent filtering for genes that prominently scored with CCCP, but not TM or CDDO, highlighted the transcriptional regulators TAF4 and GABPB1, glycolysis factors SLC2A1 and TPI1, and RNA binding proteins RBM27 and CLUH (KIAA0664). Moreover, the signature contained the mitochondrial proteins ATP5IF1 (ATPIF1) and OMA1. Most strikingly, it revealed a strong requirement for HRI (EIF2AK1) and the scarcely studied protein DELE1 (KIAA0141) (Fig. 1a, Extended Data Fig. 5a-b). Cellular dynamics of DELE1Given the scant knowledge on DELE1 and the unexpected involvement of HRI, we first sought to validate their requirement in a panel of cell systems including non-transformed cells, and indeed could confirm their importance in all cases (Extended Data Fig. 5c). Furthermore, CHOP induction also depended on DELE1 and HRI for other types of mitochondrial stress, including inhibition of complex V (oligomycin), TRAP1 (GTPP), and genetic ablation of LONP1 (Extended Data Fig. 5d-f). Failure to induce CHOP after stimulation with CCCP was preceded by a defect in EIF2α phosphorylation in HRI-or DELE1-deficient cells, suggesting that like HRI, DELE1 operates upstream of this event (Extended Data Fig. 5g). Strikingly, expression of HRI in DELE1 knockout cells was able to partially restore CHOP induction, whereas DELE1 expression in HRI-deficient cells was unproductive (Fig. 2a, Extended Data Fig. 6a-b). This indicated that DELE1 requires HRI to trigger CHOP but not vice versa, suggesting that DELE1 may act upstream of both EIF2α and HRI. Given that DELE1 is a mitochondrial protein 12 (Extended Data Fig. 6c), whereas HRI resides in the cytoplasm, we next wondered whether the activity of DELE1 towards HRI might be regulated by its localization. To test this hypothesis, we investigated if artificially rerouting DELE1 to the cytosol would bypass the need for a mitochondrial insult to provoke CHOP expression. Indeed, expression of a DELE1 mutant lacking the mitochondrial targeting sequence (DELE1 ∆MTS ) yielded a predominantly cytoplasmic protein that readily induced CHOP expression independently of CCCP (Fig. 2b-c, Extended Data Fig. 6d-e). This constitutively active version of DELE1 still required HRI to induce CHOP, underscoring its likely role as an activator of HRI. Based on these findings, we asked whether the activity of wild-type DELE1 might be regulated via a similar mechanism. Indeed, while DELE1 localized to mitochondria in unperturbed cells, it could be detected in the cytosol upon CCCP treatment (Fig. 2d). We did not ob...

The formation of blood in the embryo is dependent on bone morphogenetic protein (BMP), but how BMP signaling intersects with other regulators of hematopoietic development is unclear. Using embryonic stem (ES) cells, we show that BMP4 first induces ventral-posterior (V-P) mesoderm and subsequently directs mesodermal cells toward blood fate by activating Wnt3a and upregulating Cdx and Hox genes. When BMP signaling is blocked during this latter phase, enforced expression of either Cdx1 or Cdx4 rescues hematopoietic development, thereby placing BMP4 signaling upstream of the Cdx-Hox pathway. Wnt signaling cooperates in BMP-induced hemogenesis, and the Wnt effector LEF1 mediates BMP4 activation of Cdx genes. Our data suggest that BMP signaling plays two distinct and sequential roles during blood formation, initially as an inducer of mesoderm, and later to specify blood via activation of Wnt signaling and the Cdx-Hox pathway.

Polycomb group response elements (PREs) mediate the mitotic inheritance of gene expression programs and thus maintain determined cell fates. By default, PREs silence associated genes via the targeting of Polycomb group (PcG) complexes. Upon an activating signal, however, PREs recruit counteracting trithorax group (trxG) proteins, which in turn maintain target genes in a transcriptionally active state. Using a transgenic reporter system, we show that the switch from the silenced to the activated state of a PRE requires noncoding transcription. Continuous transcription through the PRE induced by an actin promoter prevents the establishment of PcG-mediated silencing. The maintenance of epigenetic activation requires transcription through the PRE to proceed at least until embryogenesis is completed. At the homeotic bithorax complex of Drosophila, intergenic PRE transcripts can be detected not only during embryogenesis, but also at late larval stages, suggesting that transcription through endogenous PREs is required continuously as an anti-silencing mechanism to prevent the access of repressive PcG complexes to the chromatin. Furthermore, all other PREs outside the homeotic complex we tested were found to be transcribed in the same tissue as the mRNA of the corresponding target gene, suggesting that anti-silencing by transcription is a fundamental aspect of the cellular memory system. Chromosomal elements termed PREs (Polycomb group response elements) mediate the mitotic inheritance of transcriptional programs, thus ensuring the stable propagation of cell fates throughout development. In the repressed state, PREs act as silencers by recruiting Polycomb group (PcG) complexes to chromatin. When in the activated mode, however, PREs are controlled by the counteracting trithorax group (trxG) proteins, which in turn promote the formation of a transcriptionally competent chromatin structure (for review, see . Besides the well studied homeotic genes in the Drosophila bithorax complex (BX-C), PREs have been shown to be associated with a number of target genes (Kassis 1994;Maurange and Paro 2002;Bloyer et al. 2003;Ringrose et al. 2003). However, despite extensive analyses of the dynamics of PcG and trxG protein association with a PRE and requirements during the establishment of either the silenced or the activated state (Orlando et al. 1998;Poux et al. 2001;Mohd-Sarip et al. 2002;Déjardin and Cavalli 2004), it is not known how the decision between the recruitment of either repressive PcG or activating trxG complexes to a PRE is taken.There is accumulating evidence that silencing represents the default state of these elements, whereas the conversion of a PRE into the active chromatin mode is triggered by the embryonic activation of the target gene promoter (Busturia and Bienz 1993;Chan et al. 1994;Paro 1998, 1999;Klymenko and Müller 2004;Sengupta et al. 2004). However, it is not clear how this transcriptional activity is communicated to a PRE and, as a consequence, which mechanism regulates the epigenetic switch of a PRE into t...

Wilson disease (WD) is a rare hereditary condition that is caused by a genetic defect in the copper-transportingATPase ATP7B that results in hepatic copper accumulation and lethal liver failure. The present study focuses on the structural mitochondrial alterations that precede clinical symptoms in the livers of rats lacking Atp7b, an animal model for WD. Liver mitochondria from these Atp7b -/-rats contained enlarged cristae and widened intermembrane spaces, which coincided with a massive mitochondrial accumulation of copper. These changes, however, preceded detectable deficits in oxidative phosphorylation and biochemical signs of oxidative damage, suggesting that the ultrastructural modifications were not the result of oxidative stress imposed by copper-dependent Fenton chemistry. In a cell-free system containing a reducing dithiol agent, isolated mitochondria exposed to copper underwent modifications that were closely related to those observed in vivo. In this cell-free system, copper induced thiol modifications of three abundant mitochondrial membrane proteins, and this correlated with reversible intramitochondrial membrane crosslinking, which was also observed in liver mitochondria from Atp7b -/-rats. In vivo, copper-chelating agents reversed mitochondrial accumulation of copper, as well as signs of intra-mitochondrial membrane crosslinking, thereby preserving the functional and structural integrity of mitochondria. Together, these findings suggest that the mitochondrion constitutes a pivotal target of copper in WD.